Merck
MRK
#49
Rank
C$431.84 B
Marketcap
C$174.85
Share price
-2.43%
Change (1 day)
61.21%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): C$4.87

According to Merck's latest financial reports the company's current EPS (TTM) is C$5.00. In 2025 the company made an earnings per share (EPS) of C$10.24 an increase over its 2024 EPS that were of C$9.50.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.87-52.42%
2025C$10.247.81%
2024C$9.504308.46%
2023C$0.22-97.32%
2022C$8.0510.92%
2021C$7.2684.68%
2020C$3.93-27.2%
2019C$5.4063.44%
2018C$3.30151.11%
2017C$1.32-54.58%
2016C$2.9030.21%
2015C$2.22-61.99%
2014C$5.85180.51%
2013C$2.09-31.82%
2012C$3.066.62%
2011C$2.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.28 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.87 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.84-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.07 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.67 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.35 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.60-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$5.00 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.46 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.93-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel